174 related articles for article (PubMed ID: 22289890)
1. Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.
McMillin DW; Delmore J; Negri JM; Vanneman M; Koyama S; Schlossman RL; Munshi NC; Laubach J; Richardson PG; Dranoff G; Anderson KC; Mitsiades CS
Blood; 2012 Apr; 119(15):e131-8. PubMed ID: 22289890
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
McMillin DW; Delmore J; Weisberg E; Negri JM; Geer DC; Klippel S; Mitsiades N; Schlossman RL; Munshi NC; Kung AL; Griffin JD; Richardson PG; Anderson KC; Mitsiades CS
Nat Med; 2010 Apr; 16(4):483-9. PubMed ID: 20228816
[TBL] [Abstract][Full Text] [Related]
3. Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model.
Xie BW; Mol IM; Keereweer S; van Beek ER; Que I; Snoeks TJ; Chan A; Kaijzel EL; Löwik CW
PLoS One; 2012; 7(2):e31875. PubMed ID: 22348134
[TBL] [Abstract][Full Text] [Related]
4. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
Zhang Y; Byun Y; Ren YR; Liu JO; Laterra J; Pomper MG
Cancer Res; 2009 Jul; 69(14):5867-75. PubMed ID: 19567678
[TBL] [Abstract][Full Text] [Related]
5. Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants.
Gritzapis AD; Dimitroulopoulos D; Paraskevas E; Baxevanis CN; Papamichail M
Cancer Immunol Immunother; 2002 Oct; 51(8):440-8. PubMed ID: 12202905
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.
Davis MI; Auld DS; Inglese J
Methods Mol Biol; 2016; 1360():47-58. PubMed ID: 26501901
[TBL] [Abstract][Full Text] [Related]
7. Quantitative bioluminescence imaging of mouse tumor models.
Tseng JC; Kung AL
Cold Spring Harb Protoc; 2015 Jan; 2015(1):pdb.prot078261. PubMed ID: 25561617
[TBL] [Abstract][Full Text] [Related]
8. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody.
Choi JR; Kim MJ; Tae N; Wi TM; Kim SH; Lee ES; Kim DH
Viruses; 2020 Jun; 12(6):. PubMed ID: 32630442
[TBL] [Abstract][Full Text] [Related]
9. Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging.
Vandergaast R; Khongwichit S; Jiang H; DeGrado TR; Peng KW; Smith DR; Russell SJ; Suksanpaisan L
Cancer Gene Ther; 2020 Apr; 27(3-4):179-188. PubMed ID: 30674994
[TBL] [Abstract][Full Text] [Related]
10. CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.
Wagner JA; Rosario M; Romee R; Berrien-Elliott MM; Schneider SE; Leong JW; Sullivan RP; Jewell BA; Becker-Hapak M; Schappe T; Abdel-Latif S; Ireland AR; Jaishankar D; King JA; Vij R; Clement D; Goodridge J; Malmberg KJ; Wong HC; Fehniger TA
J Clin Invest; 2017 Nov; 127(11):4042-4058. PubMed ID: 28972539
[TBL] [Abstract][Full Text] [Related]
11. Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals.
Klerk CP; Overmeer RM; Niers TM; Versteeg HH; Richel DJ; Buckle T; Van Noorden CJ; van Tellingen O
Biotechniques; 2007 Jul; 43(1 Suppl):7-13, 30. PubMed ID: 17936938
[TBL] [Abstract][Full Text] [Related]
12. In vivo bioluminescence imaging.
Sato A; Klaunberg B; Tolwani R
Comp Med; 2004 Dec; 54(6):631-4. PubMed ID: 15679260
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Firefly Luciferase Reporter Assays.
Siebring-van Olst E; van Beusechem VW
Methods Mol Biol; 2018; 1755():19-29. PubMed ID: 29671260
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography.
Genevois C; Loiseau H; Couillaud F
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27809256
[TBL] [Abstract][Full Text] [Related]
15. Measuring brain tumor growth: combined bioluminescence imaging-magnetic resonance imaging strategy.
Jost SC; Collins L; Travers S; Piwnica-Worms D; Garbow JR
Mol Imaging; 2009; 8(5):245-53. PubMed ID: 19796602
[TBL] [Abstract][Full Text] [Related]
16. A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity.
Sherman H; Gitschier HJ; Rossi AE
Front Immunol; 2018; 9():857. PubMed ID: 29740450
[TBL] [Abstract][Full Text] [Related]
17. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
[TBL] [Abstract][Full Text] [Related]
19. Uninterrupted monitoring of drug effects in human-induced pluripotent stem cell-derived cardiomyocytes with bioluminescence Ca
Suzuki K; Onishi T; Nakada C; Takei S; Daniels MJ; Nakano M; Matsuda T; Nagai T
BMC Res Notes; 2018 May; 11(1):313. PubMed ID: 29776438
[TBL] [Abstract][Full Text] [Related]
20. Integrated imaging approach to tumor model mice using bioluminescence imaging and magnetic resonance imaging.
Inoue Y; Masutani Y; Kiryu S; Haishi T; Watanabe M; Tojo A; Ohtomo K
Mol Imaging; 2010 Jun; 9(3):163-72. PubMed ID: 20487682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
